Maki RG, D'Adamo DR, Keohan ML, Saulle M, Schuetze SM, Undevia SD, et al
This is not medical advice and is not intended to be a substitute for professional medical advice, diagnosis, or treatment
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Ozempic specifically for glycaemic control in adults with type 2 diabetes, often in combination with other glucose-lowering medications or as monotherapy when metformin is not tolerated
Originally developed for type 2 diabetes management, these medications have been authorised for weight management in individuals with obesity or those who are overweight with weight-related health conditions
If your mornings are unpredictable, the injectable is genuinely easier to manage